@FiercePharma: Top-read on FP this weekend: Sun issues third recall since announcing deal to buy Ranbaxy. Article | Follow @FiercePharma
@TracyStaton: ICYMI: MannKind says it won't launch Afrezza without a partner. We updated our story. | Follow @TracyStaton
@EricPFierce: ICYMI last week: Weak link in the supply chain. Pharmacist walks out of NY hospital with 1,500 oxycodone tabs. Report | Follow @EricPFierce
@CarlyHFierce: ICYMI: Solid PhIII brings Sanofi closer to blockbuster dengue sales. FierceVaccines story | Follow @CarlyHFierce
> Merck KGaA's pharma chief, Stefan Oschmann, says he's not looking for a merger of equals, but is shopping for mid-sized acquisitions. Report
> India has capped prices on more than 100 drugs in a move likely to slash profit margins at local units of multinational drugmakers, including Sanofi ($SNY) and Abbott Laboratories ($ABT). Report
> Nestlé's new dermatology unit Galderma amped up its partnership with the French drugmaker Ipsen, with plans to boost sales of a Botox competitior. Report
> Italy's Rovati family can't catch a break: After failing to sell Rottapharm, the family proposed an IPO, but investors wouldn't bite. Report
Medical Device News
@FierceMedDev: Massachusetts med tech outfit wins $1M from NIH to develop pediatric stent system. Story | Follow @FierceMedDev
@StacyALawrence: ICYMI last week: FDA clears oral sleep apnea device, as search for CPAP alternatives continues. Story | Follow @StacyALawrence
@VarunSaxena2: FDA panel recommends stronger labeling, limiting use of power morcellation--agency may go farther. Article | Follow @VarunSaxena2
@MichaelGFierce: MIT, MicroCHIPS develop remote-controlled contraceptive with on-off delivery. More | Follow @MichaelGFierce
@EmilyWFierce: Global infectious diseases are infiltrating the Times' crossword puzzles. Here's a roundup of clues: More | Follow @EmilyWFierce
> Virtual Finger provides faster, better way to study 3D images. Item
> Virtual reality headset and Google Glass team up in Spanish surgery. Report
Biotech News
@FierceBiotech: Fresh off Phase III success, Otonomy shoots for an $86M IPO. Story | Follow @FierceBiotech
@JohnCFierce: I'm soon going offline for a week. @DamianFierce will be holding down the fort. Please postpone all big biotech news until I get back. :) | Follow @JohnCFierce
@DamianFierce: Via @WSJ, $ABBV + $SHPG would leapfrog $LLY. More | Follow @DamianFierce
@EmilyMFierce: Like in Humans, Genes Drive Half of Chimp Intelligence, Study Finds via @NatGeo. Article | Follow @EmilyMFierce
> Does crowdfunding work in biotech? Item
> President's advisory group calls for clinical trial changes, incentives for antibiotics R&D. More
> Roche and Exelixis herald a Phase III victory for their melanoma combo. News
CRO News
> China's HD Bio teams with Marshall U. for cancer R&D. Article
> CMOs eye Russia for growth. Item
> InVentiv joins a nonprofit effort to make trials more efficient. News
> Risk-sharing CRO Ergomed banks $18.9M and awaits a U.K. IPO. Story
> U.K. CRO emerges from $100M in deals with plans for more M&A. Article
Biotech IT News
> Google creates new cash source for European biotech IT startups with $100M VC fund. News
> Row over IT focus of Europe's brain project prompts 280 scientists to threaten a boycott. Story
> PHT prioritizes Android over Apple in preparation for 'bring your own device' trials. Article
> FDA warns Gilead over 'misleading' paid search link. Item
> After working to mimic the brain for 9 years, Numenta reflects on limitations of today's hardware. Story
Animal Health News
> PEDv diagnostic hits market as vets predict 2.5 million more deaths. Story
> U.K. animal care company profits from generic pet meds. Article
> Industry Voices: How to win at animal health. Report
> Vets may soon be able to carry scheduled drugs. News
> Report: China animal vaccine market up by 26%. Story
And Finally... New York Gov. Andrew Cuomo is catching flak for his plans to use Gilead Sciences' ($GILD) Truvada to prevent the spread of HIV. Report